These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2361639)

  • 21. Danazol--a new medical treatment for endometriosis.
    Fraser IS
    Med J Aust; 1978 Jul; 2(2):56-7. PubMed ID: 713913
    [No Abstract]   [Full Text] [Related]  

  • 22. Danazol: an antigonadotropic agent in the treatment of pelvic endometriosis.
    Lauersen NH; Wilson KH; Birnbaum S
    Am J Obstet Gynecol; 1975 Dec; 123(7):742-7. PubMed ID: 1200068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preliminary observations on the use of danazol in endometriosis compared to oestrogen/progestogen combination therapy.
    Noble AD; Letchworth AT
    J Int Med Res; 1977; 5 Suppl 3():79-80. PubMed ID: 334612
    [No Abstract]   [Full Text] [Related]  

  • 24. Hormonal management of endometriosis (danazol in particular).
    Greenblatt RB
    Prog Clin Biol Res; 1982; 112 Pt B():153-66. PubMed ID: 7163308
    [No Abstract]   [Full Text] [Related]  

  • 25. Experience with danazol in severe and extensive endometriosis.
    Ingerslev M
    J Int Med Res; 1977; 5 Suppl 3():81-5. PubMed ID: 913885
    [No Abstract]   [Full Text] [Related]  

  • 26. On the origin and significance of serum CA-125 concentrations in 97 patients with endometriosis before, during, and after buserelin acetate, nafarelin, or danazol.
    Franssen AM; van der Heijden PF; Thomas CM; Doesburg WH; Willemsen WN; Rolland R
    Fertil Steril; 1992 May; 57(5):974-9. PubMed ID: 1533376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of danazol in the treatment of severe endometriosis.
    Rönnberg L; Ylöstalo P; Järvinen PA
    Postgrad Med J; 1979; 55 Suppl 5():21-6. PubMed ID: 537949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Danazol-induced pseudomenopause in the management of endometriosis.
    Dmowski WP
    Clin Obstet Gynecol; 1988 Dec; 31(4):829-39. PubMed ID: 3067931
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of danazol, gonadotropin-releasing hormone agonist, and estrogen/progestogen combination on experimental endometriosis in the ovariectomized rat.
    Henig I; Rawlins RG; Weinrib HP; Dmowski WP
    Fertil Steril; 1988 Feb; 49(2):349-55. PubMed ID: 3123280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum CA 125 as a marker for patients with external endometriosis.
    Takahashi K; Kijima S; Yoshino K; Shibukawa T; Kitao M
    Int J Fertil; 1989; 34(2):143-8. PubMed ID: 2565317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of tumour markers CA125, CASA and OSA in minimal/mild endometriosis.
    Ward BG; McGuckin MA; Ramm L; Forbes KL
    Aust N Z J Obstet Gynaecol; 1991 Aug; 31(3):273-5. PubMed ID: 1804094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormonal effects of danazol and medical oophorectomy in endometriosis.
    Meldrum DR; Pardridge WM; Karow WG; Rivier J; Vale W; Judd HL
    Obstet Gynecol; 1983 Oct; 62(4):480-5. PubMed ID: 6350956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical experience with danazol treatment of endometriosis and mastopathy].
    Pavelka R; Schneider WH
    Wien Klin Wochenschr; 1981 Oct; 93(19):595-9. PubMed ID: 6798763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex steroid levels during treatment of endometriosis.
    Hirschowitz JS; Soler NG; Wortsman J
    Obstet Gynecol; 1979 Oct; 54(4):448-50. PubMed ID: 492624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes of plasma lipids and lipoprotein levels during danazol treatment for endometriosis.
    Schweppe KW; Assmann G
    Horm Metab Res; 1984 Nov; 16(11):593-7. PubMed ID: 6510890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic potential of serum CA 125 levels in danazol-treated patients with external endometriosis: a preliminary study.
    Takahashi K; Yoshino K; Kusakari M; Katoh S; Shibukawa T; Kitao M
    Int J Fertil; 1990; 35(4):226-9. PubMed ID: 1977715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Danazol--a versatile pharmacologic agent.
    Reyniak JV; Lauerson NH
    Fertil Steril; 1982 Apr; 37(4):475-7. PubMed ID: 7067843
    [No Abstract]   [Full Text] [Related]  

  • 38. Danazol: an antigonadotrophic agent in the treatment of recurrent pelvic and intestinal endometriosis.
    Ingerslev M
    Acta Obstet Gynecol Scand; 1977; 56(4):343-6. PubMed ID: 602701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the efficacy and safety of buserelin vs danazol in the treatment of endometriosis. Protocol 310 Study Group.
    Dawood MY; Spellacy WN; Dmowski WP; Gambrell RD; Greenblatt RB; Girard Y; Lemay A; Mishell DR; Nagamani M; Pepperell RJ
    Prog Clin Biol Res; 1990; 323():253-67. PubMed ID: 2106142
    [No Abstract]   [Full Text] [Related]  

  • 40. Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. The Zoladex Endometriosis Study Group.
    Rock JA; Truglia JA; Caplan RJ
    Obstet Gynecol; 1993 Aug; 82(2):198-205. PubMed ID: 8336864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.